Correlation Between Processa Pharmaceuticals and Resverlogix Corp

Can any of the company-specific risk be diversified away by investing in both Processa Pharmaceuticals and Resverlogix Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Processa Pharmaceuticals and Resverlogix Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Processa Pharmaceuticals and Resverlogix Corp, you can compare the effects of market volatilities on Processa Pharmaceuticals and Resverlogix Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Processa Pharmaceuticals with a short position of Resverlogix Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Processa Pharmaceuticals and Resverlogix Corp.

Diversification Opportunities for Processa Pharmaceuticals and Resverlogix Corp

0.23

Correlation Coefficient

Processa Pharmaceuticals  Resverlogix Corp

Modest diversification

The 3 months correlation between Processa and Resverlogix is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding Processa Pharmaceuticals and Resverlogix Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Resverlogix Corp and Processa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Processa Pharmaceuticals are associated (or correlated) with Resverlogix Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Resverlogix Corp has no effect on the direction of Processa Pharmaceuticals i.e., Processa Pharmaceuticals and Resverlogix Corp go up and down completely randomly.

Pair Corralation between Processa Pharmaceuticals and Resverlogix Corp

Given the investment horizon of 90 days Processa Pharmaceuticals is expected to under-perform the Resverlogix Corp. But the stock apears to be less risky and, when comparing its historical volatility, Processa Pharmaceuticals is 3.58 times less risky than Resverlogix Corp. The stock trades about -0.28 of its potential returns per unit of risk. The Resverlogix Corp is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  4.00  in Resverlogix Corp on December 29, 2024 and sell it today you would lose (1.00) from holding Resverlogix Corp or give up 25.0% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Processa Pharmaceuticals  vs.  Resverlogix Corp

Processa Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Processa Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Resverlogix Corp

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Resverlogix Corp are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak fundamental indicators, Resverlogix Corp reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Processa Pharmaceuticals and Resverlogix Corp

The main advantage of trading using opposite Processa Pharmaceuticals and Resverlogix Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Processa Pharmaceuticals position performs unexpectedly, Resverlogix Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Resverlogix Corp will offset losses from the drop in Resverlogix Corp's long position.

The idea behind Processa Pharmaceuticals and Resverlogix Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.